Component: (Network and Table)
Network
00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS
(http://www.americanrenal.com/role/StatementConsolidatedStatementsOfOperations)
Table(Implied)
Slicers (applies to each fact value in each table cell)
CONSOLIDATED STATEMENTS OF OPERATIONSPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS
 
 
 
Patient service operating revenues
756,329,000  
657,505,000  
563,550,000  
Provision for uncollectible accounts
(6,562,000) 
(4,524,000) 
(2,816,000) 
Net patient service operating revenues
749,767,000  
 
652,981,000  
 
560,734,000  
 
Operating expenses:
 
 
 
Patient care costs
452,449,000  
390,949,000  
329,847,000  
General and administrative
127,631,000  
77,250,000  
63,026,000  
Transaction-related costs (Note 3)
2,239,000  
2,086,000  
 
Depreciation and amortization
33,862,000  
31,846,000  
28,527,000  
Certain legal matters (Note 20)
6,779,000  
  
Total operating expenses
622,960,000  
 
502,131,000  
 
421,400,000  
 
Operating income
126,807,000  
 
150,850,000  
 
139,334,000  
 
Interest expense, net
(35,933,000) 
(45,400,000) 
(44,070,000) 
Loss on early extinguishment of debt
(4,708,000) 
  
Income tax receivable agreement income
1,286,000  
  
Income before income taxes
87,452,000  
 
105,450,000  
 
95,264,000  
 
Income tax expense (benefit)
(753,000) 
12,373,000  
12,858,000  
Net income
88,205,000  
 
93,077,000  
 
82,406,000  
 
Less: Net income attributable to noncontrolling interests
(88,590,000) 
(74,232,000) 
(66,209,000) 
Net income (loss) attributable to American Renal Associates Holdings, Inc
(385,000) 
 
18,845,000  
 
16,197,000  
 
Earnings (loss) per share (Note 15):
 
 
 
Basic (in dollars per share)
(.28) 
.85  
.74  
Diluted (in dollars per share)
(.28) 
.83  
.73  
Weighted-average number of common shares outstanding
 
 
 
Basic (in shares)
28,118,673  
22,153,451  
21,930,398  
Diluted (in shares)
28,118,673  
22,707,874  
22,332,887  
Cash dividends declared per share
1.30